Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
about
Cancer stem cells in small cell lung cancerA phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours.Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma.Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.Small cell lung cancer: therapies and targetsDetermination of Bendamustine in Human Plasma and Urine by LC-FL Methods: Application in a Drug MonitoringBendamustine as a model for the activity of alkylating agents.Bendamustine (treanda) for chronic lymphocytic leukemia: a brief overviewEmerging drugs for small-cell lung cancer.Relapsed small cell lung cancer: treatment options and latest developments.Bendamustine: a new treatment option for chronic lymphocytic leukemia.Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancerSecond-line therapy for small-cell lung cancer.An old drug with a new future: bendamustine in multiple myeloma.Chemotherapy advances in small-cell lung cancerTherapies in the pipeline for small-cell lung cancer.Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma?Single-agent chemotherapy compared with combination chemotherapy as second-line treatment in extensive-stage small cell lung cancer: a retrospective analysis.Second-line treatments of small-cell lung cancers.Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
P2860
Q26767026-B93930BA-70DE-497D-BFEF-CBA384CFCC24Q33375169-37572B43-8F1A-4EE4-9328-7B36BBCA1E06Q33388177-169FF50C-1D1E-45EB-849C-695A5E74738EQ33395564-61A89053-AF80-42EE-B902-0CA929890C8BQ34250859-92EAB510-C6F9-4B5D-B8E9-6AAB425CF6E8Q37059359-084669E1-DFD3-49F7-A53B-823F4F868688Q37179377-E97A138A-B3B2-4C85-A834-F8E87ADDF5A3Q37229148-F26B634C-268D-4690-BC56-6326CFD84409Q37582918-70F5EAF4-51C4-4C2E-9BB7-C6E9E7B6883AQ37598178-313135C0-3C05-4E36-8DA7-1F357AE1218CQ37621558-70AEF8D6-299B-41D9-8327-A4B4B90DDCA8Q37709245-49E3A9B3-0113-4C7C-B890-61E64855235DQ37866795-184E1969-C56F-4FCD-9DB6-29A9B2DA6218Q38139989-880206F3-AE83-47AF-9B18-969CEAB4C498Q38155856-0F0CD097-F18C-40A0-9F5D-4197CF7F8312Q38871386-893BB6FE-F9EA-4EEE-917C-26E9ECB507ECQ39359493-8D65BAA2-E839-4D4E-9E0D-343C4A7B6E4AQ40002016-48BAA178-9CB1-48DC-B062-058BEE5C8F8DQ43773280-6665F655-119C-4C1F-A397-BFB766510834Q47789861-FE5B3D32-4A76-4FB4-9751-D1DE4852935EQ50611105-647BADE6-8AB5-489B-B8E0-30BC60D521B1Q52148959-E66FDFD9-D7C0-428A-8F2C-3FEBCB7998E8
P2860
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phase II trial of second-line ...... all cell lung cancer patients.
@ast
Phase II trial of second-line ...... all cell lung cancer patients.
@en
type
label
Phase II trial of second-line ...... all cell lung cancer patients.
@ast
Phase II trial of second-line ...... all cell lung cancer patients.
@en
prefLabel
Phase II trial of second-line ...... all cell lung cancer patients.
@ast
Phase II trial of second-line ...... all cell lung cancer patients.
@en
P2093
P1433
P1476
Phase II trial of second-line ...... all cell lung cancer patients.
@en
P2093
Alexander Schmittel
Eckhard Thiel
Karsten Schulze
Maren Knödler
Patricia Hortig
Ulrich Keilholz
P304
P356
10.1016/J.LUNGCAN.2006.09.029
P577
2006-11-13T00:00:00Z